REGENERON PHARMACEUTICALS, INC. Proceeds from Stock Issuance 2008-2026 | REGN
Beta
What is REGENERON PHARMACEUTICALS, INC.'s current proceeds from stock issuance?
REGENERON PHARMACEUTICALS, INC. (REGN) annual proceeds from stock issuance for 2025 was $635.9M, a 56.60% decline from 2024. REGENERON PHARMACEUTICALS, INC. proceeds from stock issuance for the quarter ending March 31, 2026 was $163.1M.
What was REGENERON PHARMACEUTICALS, INC.'s proceeds from stock issuance in 2024?
REGENERON PHARMACEUTICALS, INC. annual proceeds from stock issuance for 2024 was $1.47B, a 27.92% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s proceeds from stock issuance in 2023?
REGENERON PHARMACEUTICALS, INC. annual proceeds from stock issuance for 2023 was $1.15B, a 24.61% decline from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year proceeds from stock issuance CAGR?
REGENERON PHARMACEUTICALS, INC. proceeds from stock issuance grew at a compound annual growth rate (CAGR) of 24.40% from FY2020 to FY2025, going from $2.58B to $635.9M over 5 years.
Proceeds from Stock Issuance History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-24.4%
FY2020
$2.58B
→
FY2025
$635.9M
080910111213141516171819202122232425
5 years selected
Proceeds from Stock Issuance History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $635.9M | -56.6% | 10-K |
| FY2024 | $1.47B | +27.9% | 10-K |
| FY2023 | $1.15B | -24.6% | 10-K |
| FY2022 | $1.52B | -9.1% | 10-K |
| FY2021 | $1.67B | -35.1% | 10-K |
| FY2020 | $2.58B | +1115.9% | 10-K |
| FY2019 | $211.8M | +85.0% | 10-K |
| FY2018 | $114.5M | -52.3% | 10-K |
| FY2017 | $240.2M | +89.6% | 10-K |
| FY2016 | $126.7M | -38.6% | 10-K |
| FY2015 | $206.4M | +63.7% | 10-K |
| FY2014 | $126.0M | +119.6% | 10-K |
| FY2013 | $57.4M | -9.7% | 10-K |
| FY2012 | $63.5M | +45.8% | 10-K |
| FY2011 | $43.6M | -78.3% | 10-K |
| FY2010 | $200.6M | +2233.0% | 10-K |
| FY2009 | $8.6M | +8.2% | 10-K |
| FY2008 | $7.9M | - | 10-K |
Company: REGENERON PHARMACEUTICALS, INC.Ticker: REGNSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →